Interleukin-21 receptor (IL-21R) is up-regulated by CD40 triggering and mediates proapoptotic signals in chronic lymphocytic leukemia B cells

被引:89
作者
de Totero, D
Meazza, R
Zupo, S
Cutrona, G
Matis, S
Colombo, M
Balleari, E
Pierri, I
Fabbi, M
Capaia, M
Azzarone, B
Gobbi, M
Ferrarini, M
Ferrini, S
机构
[1] Ist Nazl Ric Canc, Dept Translat Oncol & Med Oncol C, I-16132 Genoa, Italy
[2] Ist Giannina Gaslini, I-16148 Genoa, Italy
[3] Univ Genoa, Dept Hematol & Oncol, Genoa, Italy
[4] Hop Paul Brousse, INSERM, U542, Natl Sante & Rech Med, Villejuif, France
关键词
D O I
10.1182/blood-2005-09-3535
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-21 (IL-21) is a member of the IL-2 cytokine family, which mediates proliferation or growth arrest and apoptosis of normal B cells, depending on their activation state. Here we demonstrate that surface IL-21 receptor (R) is expressed at variable levels by chronic lymphocytic leukemia (CLL) B cells freshly isolated from 33 different patients. IL-21 R expression was up-regulated following cell stimulation via surface CD40. Therefore, IL-21 effects were more evident in CD40-activated CLL B cells. IL-21 induced an early signaling cascade in CLL B cells, which included JAK-1 and JAK-3 autophosphorylation and tyrosine phosphorylation of STAT-1, STAT-3, and STAT-5. IL-21 signaling failed to stimulate CLL B-cell proliferation, but induced their apoptosis. In addition, IL-21 counteracted the proliferative and antiapoptotic signals delivered by IL-15 to CLL B cells. IL-21-mediated apoptosis involved activation of caspase-8 and caspase-3, cleavage of Bid to its active form t-Bid, and cleavage of PARP and of p27Kip-1. Recent data indicate that CLL B cells require interaction with the microenvironment for their survival and expansion. The present findings thus provide a set of new mechanisms involved in the balance between cell-survival and apoptotic signals in CLL B cells.
引用
收藏
页码:3708 / 3715
页数:8
相关论文
共 53 条
[1]   Cutting edge:: The common γ-chain is an indispensable subunit of the IL-21 receptor complex [J].
Asao, H ;
Okuyama, C ;
Kumaki, S ;
Ishii, N ;
Tsuchiya, S ;
Foster, D ;
Sugamura, K .
JOURNAL OF IMMUNOLOGY, 2001, 167 (01) :1-5
[2]  
Battle TE, 2003, CLIN CANCER RES, V9, P2166
[3]   Flavopiridol downregulates the expression of both the inducible NO synthase and p27kip1 in malignant cells from B-cell chronic lymphocytic leukemia [J].
Billard, C ;
Kern, C ;
Tang, R ;
Ajchenbaum-Cymbalista, F ;
Kolb, JP .
LEUKEMIA, 2003, 17 (12) :2435-2443
[4]   Interleukin-21 is a growth and survival factor for human myeloma cells [J].
Brenne, AT ;
Ro, TB ;
Waage, A ;
Sundan, A ;
Borset, M ;
Hjorth-Hansen, H .
BLOOD, 2002, 99 (10) :3756-3762
[5]   B-cell chronic lymphocytic leukemia: A bird of a different feather [J].
Caligaris-Cappio, F ;
Hamblin, TJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :399-408
[6]   Mechanisms of disease: Chronic lymphocytic leukemia [J].
Chiorazzi, N ;
Rai, KR ;
Ferrarini, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :804-815
[7]   ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia [J].
Crespo, M ;
Bosch, F ;
Villamor, N ;
Bellosillo, B ;
Colomer, D ;
Rozman, M ;
Marcé, S ;
López-Guillermo, A ;
Campo, E ;
Montserrat, E .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (18) :1764-1775
[8]   Interleukin-11 induces Th2 polarization of human CD4+ T cells [J].
Curti, A ;
Ratta, M ;
Corinti, S ;
Girolomoni, G ;
Ricci, F ;
Tazzari, P ;
Siena, M ;
Grande, A ;
Fogli, M ;
Tura, S ;
Lemoli, RM .
BLOOD, 2001, 97 (09) :2758-2763
[9]   CHRONIC LYMPHOCYTIC LEUKEMIA - AN ACCUMULATIVE DISEASE OF IMMUNOLOGICALLY INCOMPETENT LYMPHOCYTES [J].
DAMESHEK, W .
BLOOD-THE JOURNAL OF HEMATOLOGY, 1967, 29 (4P2) :566-&
[10]   Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia [J].
Damle, RN ;
Wasil, T ;
Fais, F ;
Ghiotto, F ;
Valetto, A ;
Allen, SL ;
Buchbinder, A ;
Budman, D ;
Dittmar, K ;
Kolitz, J ;
Lichtman, SM ;
Schulman, P ;
Vinciguerra, VP ;
Rai, KR ;
Ferrarini, M ;
Chiorazzi, N .
BLOOD, 1999, 94 (06) :1840-1847